Leveraging real-world data to advance biomarker discovery and precision oncology
Cancer Cell · 2025-04 · 43 (4) · 606-610
DOI: 10.1016/j.ccell.2025.03.012 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Cell, 2025-04. Verfasst von Jiaqian Luo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; BCMB Allied Program, Graduate School of Medical S…. Hauptthemen laut MEDLINE: Precision Medicine, Biomarkers, Tumor, Neoplasms, Medical Oncology. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: National Institutes of Health, National Institutes of Health National Cancer Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; BCMB Allied Program, Graduate School of Medical Sciences, Weill Cornell Medicine, New York, NY, USA.
- Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, US…
Förderung
- National Institutes of Health
- National Institutes of Health National Cancer Institute
Zitieren
APA
Luo, J., & Solit, D. B. (2025). Leveraging real-world data to advance biomarker discovery and precision oncology. Cancer Cell, 43(4), 606-610. https://doi.org/10.1016/j.ccell.2025.03.012
Vancouver
Luo J, Solit DB. Leveraging real-world data to advance biomarker discovery and precision oncology. Cancer Cell. 2025;43(4):606-610. doi:10.1016/j.ccell.2025.03.012
BibTeX
@article{Luo2025,
author = {Luo, Jiaqian and Solit, David B},
title = {Leveraging real-world data to advance biomarker discovery and precision oncology},
journal = {Cancer Cell},
year = {2025},
volume = {43},
number = {4},
pages = {606--610},
doi = {10.1016/j.ccell.2025.03.012}
}
EUVIMED